Both in Pharmaceuticals
CorMedix vs CytomX Therapeutics
Over the past year CRMD returned −33.1% and CTMX returned −14.9%; their daily moves had a correlation of 0.17.
CRMD −33.1% CTMX −14.9%Growth of $1, one year, split-adjusted
| Metric | CRMD | CTMX |
|---|---|---|
| Price | $7.93 | $2.75 |
| Market cap | $618.1M | $599.2M |
| Today | +0.51% | +2.23% |
| 1 month | −4.5% | −14.3% |
| 6 months | +20.7% | −37.6% |
| Year to date | −31.8% | −35.4% |
| 1 year | −29.8% | −5.2% |
| Revenue growth (YoY) | +156.5% | −92.4% |
| Gross margin | 75.7% | 100.0% |
| Net margin | 25.5% | −1457.4% |
| P/E (TTM) | 3.3× | — |
| Price / sales | 1.3× | 32.7× |
| Net cash | $256.7M | $330.3M |
| Dividend yield | — | — |
| Volatility (60d) | 48.9% | 60.5% |
| Short % of float | 23.0% | 19.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).